Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

736.37
-4.6755-0.63%
Number of Gainers:13
Number of Losers:36
Number of Flat:4
PE:- -
High:740.84
Open:740.84
Low:732.01
Close:741.05
Volume:53.34M
Turnover:756.42M
Market Cap:124.16B
Float Cap:77.22B

Loading ...

Aterian Replaces Auditor UHY with Haskell & White

Reuters
·
Oct 06

Tronox Updates Financial Calendar with Third-Quarter Earnings Release, Webcast Call

Reuters
·
Oct 06

iRhythm Holdings Price Target Raised to $194.00/Share from $192.00 by Needham

Dow Jones
·
Oct 06

Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), Pacira Pharmaceuticals (PCRX)

TIPRANKS
·
Oct 06

Primer: Li Auto (LI US) - Oct 2026

Smartkarma
·
Oct 06

Wendel names Bénédicte Rabier Chief Product Officer to bolster private assets push

TIPRANKS
·
Oct 06

Press Release: Datasea Reports Fiscal Year 2026 Results with Gross Profit up 70.1% and Gross Margin Increased to 10.2% Despite Lower Revenue

Dow Jones
·
Oct 05

Analysts Conflicted on These Healthcare Names: Capricor Therapeutics (CAPR), Alector (ALEC) and Irhythm Technologies (IRTC)

TIPRANKS
·
Oct 05

Needham Lifts Price Target on iRhythm Technologies to $194 From $192, Keeps Buy Rating

MT Newswires Live
·
Oct 05

iRhythm Holdings, Inc : Needham Raises Target Price to $194 from $192

THOMSON REUTERS
·
Oct 05

iRhythm Acquires VitalConnect to Expand Cardiac Monitoring

TIPRANKS
·
Oct 05

iRhythm Completes VitalConnect Acquisition for $237.5 Million Cash, Issues up to 423,334 Shares

Reuters
·
Oct 05

iRhythm Completes Acquisition of Vitalconnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

THOMSON REUTERS
·
Oct 05

Immunome - Pays Bms $20 Mln Cash and Issues 4,425,487 Shares as Amendment Consideration - SEC Filing

THOMSON REUTERS
·
Oct 05

Immunome - Has no Further Payment Obligations to Bms Under License Agreement - SEC Filing

THOMSON REUTERS
·
Oct 05

Immunome - Enters Amendment No. 4 to License Agreement with Bristol-Myers Squibb Company on Oct 2, 2026 - SEC Filing

THOMSON REUTERS
·
Oct 05

Immunome - Amendment Removes Co's Milestone & Royalty Payment Obligations and Assigns Patent Rights Related to Varegacestat, Al101 - SEC Filing

THOMSON REUTERS
·
Oct 05

Where Food Comes From, Inc. Announces Broad Expansion of RaiseWell® Certified Program with Whole Foods Market

GlobeNewswire
·
Oct 05

Mizuho Initiates REGENXBIO at Outperform With $22 Price Target

MT Newswires Live
·
Oct 05

Morgan Stanley's Long Position in Shares of Bilibili Decreases to 5.98% on Sept 29 from 7.27% - HKEX

THOMSON REUTERS
·
Oct 05